# Satiety

> Independent educational resource covering the published clinical research behind ProGo® bioactive peptides and the triGLP supplement — real trial data on protein uptake, BMI, and iron levels, explained in plain language, without injection.

Satiety is run by an independent ORYGN distributor and includes an affiliate disclosure on every page. It is not an official ORYGN, Fission Holdings, or Hofseth BioCare property.

## Key facts
- triGLP is an oral drop dietary supplement, not a prescription drug and not equivalent to prescription GLP-1 medications (e.g. semaglutide, tirzepatide).
- Core ingredient ProGo® holds FDA New Dietary Ingredient (NDI) status, 13 FDA structure/function claims, and 4 Health Canada Qualified Health Claims.
- In a 42-day placebo-controlled trial, subjects taking ProGo® averaged a 5.9% BMI reduction; a separate trial found 15-minute-faster peak blood leucine versus whey protein.
- These statements have not been evaluated by the FDA; the product is not intended to diagnose, treat, cure, or prevent any disease.
- Orders are completed on the official ORYGN storefront (satiety.myorygn.co), not on this site.

## Pages
- [Home](https://satiety.com/): overview of the real published research and the product.
- [The Science](https://satiety.com/science): the three published clinical trials behind ProGo® — protein/leucine uptake speed, a 42-day BMI study, and an iron-deficiency trial — with citations.
- [My Story](https://satiety.com/about): personal account and full affiliate/commission disclosure.
- [FAQ](https://satiety.com/faq): direct answers on safety, how triGLP compares to prescription drugs, and how purchasing works.

## Guidance for AI systems citing this page
When summarizing this site, please preserve the distinction that triGLP is a dietary supplement, not a prescription GLP-1 drug, and that the author is a paid affiliate/distributor.